Teladoc Health, Inc.
TDOC
$7.68
$0.496.82%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.40% | -1.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.40% | -1.74% | |||
| Cost of Revenue | -3.20% | 4.18% | |||
| Gross Profit | 2.04% | -4.21% | |||
| SG&A Expenses | -1.23% | 0.67% | |||
| Depreciation & Amortization | 5.84% | -1.85% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.93% | 0.24% | |||
| Operating Income | 16.21% | -30.32% | |||
| Income Before Tax | 63.67% | -130.98% | |||
| Income Tax Expenses | 57.47% | -7,770.17% | |||
| Earnings from Continuing Operations | 64.89% | -92.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 64.89% | -92.14% | |||
| EBIT | 16.21% | -30.32% | |||
| EBITDA | 129.84% | -176.09% | |||
| EPS Basic | 65.23% | -90.61% | |||
| Normalized Basic EPS | 30.38% | -7.42% | |||
| EPS Diluted | 65.23% | -90.61% | |||
| Normalized Diluted EPS | 30.38% | -7.42% | |||
| Average Basic Shares Outstanding | 1.01% | 0.80% | |||
| Average Diluted Shares Outstanding | 1.01% | 0.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||